Profile
Sofimac Innovation is a venture capital firm that has made its mark by focusing on the development of innovative companies. Headquartered in France, the firm has built a team with a strong background in capital investment, fostering a culture that deeply understands the technical and market dynamics of numerous sectors. Its composition comprises experienced investors who collaborate closely with entrepreneurs to guide them through strategic growth stages.
The firm invests primarily in industries such as biotechnology, digital technology, and industrial innovations, aiming to support startups from the seed stage to later stages of development. Sofimac Innovation typically provides funding ranging between $1-5 million depending on the maturity and needs of the business. The firm has managed multiple funds, backed by a diverse range of limited partners, and is recognized for its commitment to nurturing high-potential startups.
Notable investments in Sofimac Innovation's portfolio include companies like Pharnext - a biopharmaceutical firm, Aryballe - a digital olfaction company, and Diabeloop - a health tech company. These investments exemplify Sofimac's focus on transformative technologies across diverse sectors, underlining their strategic intent to drive innovation at scale.
Industry
Sofimac Innovation Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Cap Entrepreneurs 2
|
Venture Capital (VC)
|
Food and Beverage
Foodtech
Healthcare Services
Software
Energy
CleanTech
|
Pre-seed
Seed
|
Europe
|
$5-10 m
|
$39 M
|
July 2021
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.